EGFR and gastric cancer: Gastric cancer cells deliver surface EGFR which is later integrated to plasma membrane of liver stromal cells through tumour‐derived EVs, resulting in activation of hepatocyte growth factor, a c‐MET ligand, via downregulation of miR‐26a/b, and modulation of a fertile microenvironment susceptible to liver metastasis.